Weed is the future, or so they say. 2018 saw a ton of overweight equities, but they have proven to be some of the most resistant names in today's market. Therefore, it stands to reason that if names like CGC, TLRY, and CRON will continue their rise, this ETF will reflect that success. It needs to retract, but will offer a great buying opportunity in the next 1-2 weeks.